Thea Helm Wiken

Thea Helm Wiken, MD, is a PhD-student working at the Department of Gastroenterology at Oslo University Hospital (OUH) in Norway. She is doing a project on switching inflammatory bowel disease patients from intravenous to subcutaneous vedolizumab maintenance treatment. Her ongoing research also includes comparing effect of vedolizumab and ustekinumab in patients with Ulcerative Colitis.